---

---

publishing date : 2022 - 03 - 28    tags : Treatment   

save search

---

Ozempic® 2.0 mg approved in the US for the treatment of type 2 diabetes
Published: 2022-03-28 (Crawled : 22:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M |

Health Technology

| 13.72% | O: 2.86% H: 0.47% C: -0.72%
ozempic treatment diabetes

---

Neurocrine Biosciences Announces Regulatory Approval of Dysval® (valbenazine) for the Treatment of Tardive Dyskinesia in Japan
Published: 2022-03-28 (Crawled : 21:00) - prnewswire.com
NBIX M | $132.03 -0.39% -0.39% 560K |

Health Technology

| 41.04% | O: 0.16% H: 0.51% C: -0.94%
dysval treatment approval

---

Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis
Published: 2022-03-28 (Crawled : 19:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -61.92% | O: -0.35% H: 0.09% C: -0.7%
CLSD P | $1.29 -2.27% -2.33% 230K |

Health Technology

| -44.49% | O: 2.97% H: 2.47% C: -3.7%
xipere treatment macular

---

Dupixent (dupilumab injection) now approved in Canada for the treatment of severe asthma in children aged six to 11 years with type 2 inflammation
Published: 2022-03-28 (Crawled : 17:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -9.9% | O: 0.0% H: 0.0% C: 0.0%
treatment dupixent children

---

Neurocrine Biosciences to Present Data on Treatment Patterns and Unmet Needs in Adult and Pediatric Patients Living with Classic Congenital Adrenal Hyperplasia at AMCP 2022
Published: 2022-03-28 (Crawled : 14:00) - biospace.com/
NBIX M | $132.03 -0.39% -0.39% 560K |

Health Technology

| 40.85% | O: -0.45% H: 1.5% C: 0.31%
treatment

---

Alzamend Neuro Announces Full Data Set From Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s
Published: 2022-03-28 (Crawled : 13:20) - biospace.com/
ALZN | $0.6894 -0.23% -0.23% 28K |

Professional, Scientific, and T...

| -44.72% | O: -1.63% H: 5.79% C: 0.83%
al001 treatment dementia trial set alzheimer’s alzheimer's phase 1

---

NLS Pharmaceutics Announces Early Access Program (EAP) Allowing Patients with Idiopathic Hypersomnia to Receive Treatment with Mazindol ER
Published: 2022-03-28 (Crawled : 13:20) - biospace.com/
NLSP | $0.1327 6.04% 74K |

| -90.85% | O: -1.41% H: 3.24% C: -5.0%
treatment program

---

Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease
Published: 2022-03-28 (Crawled : 13:00) - globenewswire.com
PRTA 4 | $21.17 2.92% 2.83% 510K |

Health Technology

| -42.73% | O: 0.38% H: 2.41% C: -0.35%
prx012 treatment fda clearance disease antibody alzheimer alzheimer’s alzheimer's disease alzheimer's anti-amyloid beta

---

Hope Springs Eternal for Inflammatory Disease Treatments at AAD 2022
Published: 2022-03-28 (Crawled : 13:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 151.3% | O: 0.8% H: 0.39% C: 0.11%
disease treatment

---

Stealth BioTherapeutics Receives Orphan Drug Designation from FDA for Elamipretide for the Treatment of Friedreich's Ataxia
Published: 2022-03-28 (Crawled : 12:20) - biospace.com/
MITO | $0.32 0.25% |

Health Technology

| -54.79% | O: 2.92% H: 2.95% C: -3.91%
treatment fda drug elamipretide friedreich's ataxia designation friedreich’s ataxia

---

Retrospective Study on Real-World Treatment Patterns and Outcomes of Acthar® Gel (Repository Corticotropin Injection) in Patients with Refractory Rheumatoid Arthritis Published in Drugs in Context
Published: 2022-03-28 (Crawled : 11:00) - prnewswire.com
MNKKQ | $0.02 |

Manufacturing

| -82.53% | O: -1.31% H: 1.77% C: 1.15%
acthar treatment

---

Hydraulic Dosing Pump Market - 49% of Growth to Originate from APAC | Driven by Growing Adoption of Hydraulic Dosing Pump for Water & Wastewater Treatment | Technavio
Published: 2022-03-28 (Crawled : 10:00) - prnewswire.com
IR | News | $88.4 -0.64% 0.0% 2.5M |

Producer Manufacturing

| 76.87% | O: -0.16% H: 0.48% C: -0.2%
treatment growing growth market

---

Philips expands network of clinical partners to set new standard of care for the early diagnosis and treatment of lung cancer
Published: 2022-03-28 (Crawled : 10:00) - globenewswire.com
PHG | $19.98 0.0% 540K |

Health Technology

| -33.62% | O: 0.7% H: 0.0% C: 0.0%
treatment care cancer set diagnostic

---

Relief Therapeutics Reports In Vivo Data Indicating Prolonged Release of Amino Acids Using its Physiomimic(TM) Technology May Have Benefits for the Treatment of PKU
Published: 2022-03-28 (Crawled : 08:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K |

n/a

| 1962.59% | O: -1.85% H: 3.62% C: 2.9%
treatment technology therapeutics

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---